Search Results - "Bolwell, B."

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies by Olsson, R F, Logan, B R, Chaudhury, S, Zhu, X, Akpek, G, Bolwell, B J, Bredeson, C N, Dvorak, C C, Gupta, V, Ho, V T, Lazarus, H M, Marks, D I, Ringdén, O T H, Pasquini, M C, Schriber, J R, Cooke, K R

“…Clinical outcomes after primary graft failure (PGF) remain poor. Here we present a large retrospective analysis ( n =23 272) which investigates means to…”
Get full text

Quality of life and outcomes in patients⩾60 years of age after allogeneic hematopoietic cell transplantation by Hamilton, B K, Rybicki, L, Dabney, J, McLellan, L, Haddad, H, Foster, L, Abounader, D, Kalaycio, M, Sobecks, R, Dean, R, Duong, H, Hill, B T, Bolwell, B J, Copelan, E A

“…Hematopoietic cell transplantation (HCT) has become an established standard of care for many older patients with hematologic malignancies. The effect of…”
Get full text

Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study by Foster, L W, McLellan, L, Rybicki, L, Dabney, J, Copelan, E, Bolwell, B

“…This prospective study validates the finding from retrospective research that having an inpatient lay care-partner (CP) is associated with better survival…”
Get full text

Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation by Tavadze, M, Rybicki, L, Mossad, S, Avery, R, Yurch, M, Pohlman, B, Duong, H, Dean, R, Hill, B, Andresen, S, Hanna, R, Majhail, N, Copelan, E, Bolwell, B, Kalaycio, M, Sobecks, R

“…Vancomycin-resistant enterococcus (VRE) is a well-known infectious complication among immunocompromised patients. We performed a retrospective analysis to…”
Get full text

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation by BOLWELL, B, SOBECKS, R, POHLMAN, B, ANDRESEN, S, RYBICKI, L, KUCZKOWSKI, E, KALAYCIO, M

“…Cyclosporine (CSP) and short course methotrexate (MTX) have been the gold standard for GVHD prophylaxis for decades. Problems associated with MTX include…”
Get full text

Effects of spleen status on early outcomes after hematopoietic cell transplantation by Akpek, G, Pasquini, M C, Logan, B, Agovi, M-A, Lazarus, H M, Marks, D I, Bornhaeüser, M, Ringdén, O, Maziarz, R T, Gupta, V, Popat, U, Maharaj, D, Bolwell, B J, Rizzo, J D, Ballen, K K, Cooke, K R, McCarthy, P L, Ho, V T

“…To assess the impact of spleen status on engraftment, and early morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT), we analyzed…”
Get full text

Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients by Hamilton, B K, Law, A D, Rybicki, L, Abounader, D, Dabney, J, Dean, R, Duong, H K, Gerds, A T, Hanna, R, Hill, B T, Jagadeesh, D, Kalaycio, M E, Lawrence, C, McLellan, L, Pohlman, B, Sobecks, R M, Bolwell, B J, Majhail, N S

“…Quality of life (QOL) is an important outcome for hematopoietic cell transplantation (HCT) recipients. Whether pre-HCT QOL adds prognostic information to…”
Get full text

Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies by BOLWELL, B. J, POHLMAN, B, SWEETENHAM, J. W, RYBICKI, L, SOBECKS, R, DEAN, R, CURTIS, J, ANDRESEN, S, KOO, A, MINEFF, V, KALAYCIO, M

“…The cellular composition of an autologous graft may influence autologous stem cell transplantation (ASCT) outcome. Etoposide (VP) plus filgrastim (G)…”
Get full text

Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemia by Mahindra, A, Bolwell, B J, Rybicki, L, Elder, P, Kalaycio, M, Dean, R, Avalos, B, Sobecks, R, Tench, S, Andresen, S, Pohlman, B, Sweetenham, J, Devine, S, Copelan, E

“…The use of etoposide (VP-16) for stem cell mobilization has been reported as a significant risk factor for the development of therapy-related…”
Get full text

Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial by Jagasia, M H, Abonour, R, Long, G D, Bolwell, B J, Laport, G G, Shore, T B, Durrant, S, Szer, J, Chen, M-G, Lizambri, R, Waller, E K

“…This prospective, randomized, double-blind, placebo-controlled study evaluated the efficacy of palifermin to reduce the incidence of severe (grade 3–4) acute…”
Get full text

Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection by Mehdi, A, Rybicki, L, Mossad, S, Yurch, M, Sekeres, M, Gerds, A T, Jagadeesh, D, Hamilton, B, Liu, H, Dean, R, Pohlman, B, Sobecks, R, Andresen, S, Kalaycio, M, Bolwell, B J, Majhail, N S, Copelan, E, Hill, B T

Get full text

Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation by Fu, S, Rybicki, L, Abounader, D, Andresen, S, Bolwell, B J, Dean, R, Gerds, A, Hamilton, B K, Hanna, R, Hill, B T, Jagadeesh, D, Kalaycio, M E, Liu, H D, Pohlman, B, Sobecks, R M, Majhail, N S

“…The relationship of socioeconomic status (SES) with long-term outcomes in allogeneic hematopoietic cell transplantation (HCT) survivors has not been well…”
Get full text

Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites by Hamilton, B K, Rybicki, L, Sekeres, M, Kalaycio, M, Hanna, R, Sobecks, R, Dean, R, Duong, H, Hill, B T, Bolwell, B, Copelan, E

“…The impact of race on outcome has been identified in a number of cancers, with African Americans having poorer survival compared with whites. We conducted a…”
Get full text

Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma by Hong, S, Rybicki, L, Abounader, D M, Bolwell, B J, Dean, R, Gerds, A T, Hamilton, B K, Hill, B T, Jagadeesh, D, Kalaycio, M, Liu, H D, Pohlman, B, Sobecks, R, Majhail, N S

“…Socioeconomic status (SES) is an important determinant of disparities in health care. The association of SES with outcomes in autologous hematopoietic cell…”
Get full text

Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation by Waterman, J, Rybicki, L, Bolwell, B, Copelan, E, Pohlman, B, Sweetenham, J, Dean, R, Sobecks, R, Andresen, S, Kalaycio, M

“…Fludarabine is an effective treatment for follicular lymphoma (FL), but exposure to it negatively impacts stem cell mobilization and may increase the risk of…”
Get full text

GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies by Nazha, A, Rybicki, L, Abounader, D, Bolwell, B, Dean, R, Gerds, A T, Jagadeesh, D, Hamilton, B K, Hill, B T, Kalaycio, M, Liu, H, Pohlman, B, Sobecks, R, Sekeres, M A, Majhail, N S

Get full text

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection by AVERY, R. K, BOLWELL, B. J, CURTIS, J, KALAYCIO, M, POHLMAN, B, WILLIAMS, J. W, YEN-LIEBERMAN, B, LURAIN, N, WALDMAN, W. J, LONGWORTH, D. L, TAEGE, A. J, MOSSAD, S. B, KOHN, D, LONG, J

“…Ganciclovir-resistant cytomegalovirus (CMV) infection is an emerging problem in transplant recipients. Foscarnet resistance and cidofovir resistance have also…”
Get full text

Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS by Sobecks, R M, Rybicki, L, Yurch, M, Kalaycio, M, Dean, R, Andresen, S, Pohlman, B, Duong, H, Bolwell, B, Copelan, E

“…BU and CY is a common conditioning regimen for allogeneic hematopoietic progenitor cell transplantation (HPCT). I.v. BU is increasingly used in place of the…”
Get full text

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation by Shaughnessy, P J, Bolwell, B J, van Besien, K, Mistrik, M, Grigg, A, Dodds, A, Prince, H M, Durrant, S, Ilhan, O, Parenti, D, Gallo, J, Foss, F, Apperley, J, Zhang, M-J, Horowitz, M M, Abhyankar, S

“…GVHD is partly mediated by host APCs that activate donor T cells. Extracorporeal photopheresis (ECP) can modulate APC function and benefit some patients with…”
Get full text

Utility of the psychosocial assessment of candidates for transplantation (PACT) scale in allogeneic BMT by Foster, L W, McLellan, L, Rybicki, L, Dabney, J, Visnosky, M, Bolwell, B

“…The psychosocial assessment of candidates for transplantation (PACT) scale was completed before the transplant on 120 patients who underwent allogeneic…”
Get full text